David Hardy, MD
Vascular Surgery · Valdosta, GANPI 1548467939
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Medtronic at 25.5% of the total.
Across 264 payments — averaging $55.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- W. L. Gore & Associates, Inc.$3K
- Globus Medical$1K
- Abbott$1K
- Bolton Medical Inc$713
- Bard Peripheral Vascular, Inc.$706
- plus $4K from 30 others
Across 45 payments — averaging $1095.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$23K
- Boston Scientific$20K
- Medtronic$3K
- Cook Research Incorporated$3K
What the payments were for
- Speaking & faculty fees$2,25015%
- Travel & lodging$3,61425%
- Food & beverage$8,28857%
- Education$3683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 23 | $3,704 |
| W. L. Gore & Associates, Inc. | 72 | $3,303 |
| Globus Medical | 7 | $1,181 |
| Abbott | 19 | $1,081 |
| Bolton Medical Inc | 10 | $713 |
| Bard Peripheral Vascular, Inc. | 8 | $706 |
| Boston Scientific | 13 | $574 |
| Shockwave Medical, Inc | 22 | $483 |
| Inari Medical, Inc. | 14 | $481 |
| Penumbra, Inc. | 7 | $351 |
| Johnson & Johnson(2 entities) | 13 | $285 |
| Endologix LLC | 2 | $248 |
| KCI USA, Inc. | 6 | $214 |
| Cardiovascular Systems Inc. | 5 | $171 |
| Terumo Medical Corporation | 5 | $154 |
| Stryker | 5 | $146 |
| Silk Road Medical, Inc. | 3 | $86 |
| Angiodynamics, Inc. | 4 | $86 |
| Baxter Healthcare | 4 | $78 |
| Atricure, Inc. | 2 | $70 |
| Abiomed | 2 | $54 |
| Smith+Nephew | 3 | $45 |
| Pfizer | 2 | $42 |
| Covidien LP | 1 | $36 |
| AstraZeneca | 1 | $28 |
| Mimedx Group, Inc. | 1 | $27 |
| Lemaitre Vascular, Inc. | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Shionogi Inc | 1 | $19 |
| AbbVie | 1 | $18 |
| LSI Solutions Inc | 1 | $17 |
| Kerecis Limited | 1 | $16 |
| Humacyte Global, Inc. | 1 | $13 |
| Flowphysix Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PIVOX Oblique Lateral Spinal System$2,250
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,079
- ALIF$991
- DIVERGENCE-L$519
- Supera peripheral stent system$286
- Relay Plus$281
- EXCLUDER AAA Endoprosthesis$276
- FLOWTRIEVER CATHETER, S$273
- GORE TAG Thoracic Branch Endoprosthesis$228
- GORE VIABAHN VBX Balloon Expandable Endo$198
- Alto Abdominal Stent Graft System$181
- Absolute Pro vascular stent system$178
- GORE TAG Thoracic Endoprosthesis$168
- Penumbra System$146
- JETI$145
- JETi Peripheral Catheter$136
- GENERAL VASCULAR INTERVENTION$132
- TAG Thoracic Endoprosthesis$130
- C3 Delivery System$130
- ENROUTE Transcarotid Neuroprotection System$120
How this compares
$14,519 in reported general payments places this provider in the 75th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,363 |
| ClopidogrelClopidogrel Bisulfate | 142 | $1,127 |
| Atorvastatin Calcium | 41 | $285 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $135 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $94 |
| Prednisone | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $7,36312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Valdosta
- Siddharth PatelAtlanta$303K
- Juan AyerdiColumbus$130K
- Albert RichardsonThomasville$103K
- Walaya Methodius-RayfordAtlanta$79K
- Eric MartinFort Gordon$64K
- William JordanAugusta$64K
- Alykhan LalaniMarietta$64K
- Charles MoomeyGainesville$52K
- Suman AnnambhotlaGainesville$48K
- Andrew UnzeitigAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.